On 10–12 May 2019, the 4th JEPE conference with the APGS (Association Pneumologique de Grande Sud) and APPEN (Association des Pneumologues de Pays de L’Est du Nord Pas de Calais) was organized. At the same time, it was the first Franco-Italian meeting of the APGS association which took place during the 4th JEPE in Stresa, Italy. The theme of the congress was “The management of Chronic Respiratory Diseases (Asthma, COPD, SAOS) in France and Italy” with the contribution of “Association Asthme et Allergies, OSPL, Apnee de Sommeil.” This support was
Tatiana Paola Pacheco Páez, German Gutierrez Parra, Alirio Rodrigo Bastidas Goyes, María Daniela Hernández Arcila, Paula Marcela Alcaraz Cañizares, Julio César García Casallas and Daniel Martin Arsanios
urgently needed as no management guidelines or antimicrobial susceptibility cutoff points are currently available regarding this bacterial genus, which is why as there has been a significant increase in Kocuria infection during the last 10 years. This article presents the case of a 71-year-old patient having a background of diabetes mellitus and chronic obstructive pulmonary disease who was admitted to a tertiary hospital because of severe community-acquired pneumonia (CAP) caused by Kocuria rosea ; he responded favourably to antibiotic management. An exhaustive
A 28.4% prevalence of bronchiectasis reported in uncontrolled moderate-to-severe asthma ( 2 ), means that one in three asthma patients experiences this type of association. Previous studies revealed that the association is related to the severity of asthma, the presence of chronic expectoration, lower levels of fractional exhaled nitric oxide (Fe NO), and a previous history of pneumonia ( 3 ). In the literature, the prevalence of bronchiectasis among patients with asthma ranges from 2.2% ( 4 ) to 77% ( 5 ). This broad variation is caused by some
Abdullah Alqallaf, Mariana Ahmad Zuber, Shehnoor Tarique and Alina A. Ionescu
-6196(12)60212-2 Prakash UBS Reiman HM Comparison of needle-biopsy with cytologic analysis for the evaluation of pleural effusion – analysis of 414 cases Mayo Clinic Proceedings 1985 60 3 158 164
6 Rodriguez-Panadero F, Janssen JP, Astoul P. Thoracoscopy: general overview and place in the diagnosis and management of pleural effusion. European Respiratory Journal 2006;28(2):409–421. 10.1183/09031936.06.00013706 Rodriguez-Panadero F Janssen JP Astoul P Thoracoscopy: general overview and place in the diagnosis and management of pleural effusion European
Carmen Loredana Ardelean, Daniel Florin Lighezan, Sorin Pescariu, Valentin Nadasan, Roxana Pleava and Stefan Mihaicuta
Undiagnosed and untreated SAS increase morbidity and mortality in HF patients and represent a significant burden on the healthcare system, with more costs and resources utilization, emphasizing the importance of early diagnosis of this disease.
This might require introduction of SAS screening as a routine method in the management of patients with HF.
Ethics approval and consent to participate
The authors declare that they have no competing interests.
1 Punjabi NM. The epidemiology of adult
pneumonitis: perspectives in diagnosis and management. American Journal of Respiratory and Critical Care Medicine 2017;196(6):680–689. 28598197 10.1164/rccm.201611-2201PP
Vasakova M Morell F Walsh S Leslie K Raghu G Hypersensitivity pneumonitis: perspectives in diagnosis and management American Journal of Respiratory and Critical Care Medicine 2017 196 6 680 689
7 Fishman A. et al. Hypersensitivity pneumonitis. Fishman’s Pulmonary Disease and Disorder 2008:1161–1172.
Fishman A. et al Hypersensitivity pneumonitis Fishman
Retno AS Soemarwoto, Jamsari, Yanwirasti, Andika Chandra Putra and Syazili Mustofa
This work was personally funded without any grant.
1 Quaderi SA, Hurst JR. The unmet global burden of COPD. Global Health, Epidemiology and Genomics 2018;3:e4–e4. 29868229 10.1017/gheg.2018.1
Quaderi SA Hurst JR The unmet global burden of COPD Global Health, Epidemiology and Genomics 2018 3 e4 e4
2 Vestbo J, Hurd SS, Agusti AG, Jones PW, Vogelmeier C, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. American Journal of Respiratory
Corina Eugenia Budin, Ruxandra Rajnoveanu, Ioana Roxana Bordea, Corina Marginean, Bianca Domokos, Elena Dantes and Doina Adina Todea
-035MS 16113470 van Eeden SF Yeung A Quinlam K Hogg JC Systemic response to ambient particulate matter: Relevance to chronic obstructive pulmonary disease Proceedings of the American Thoracic Society 2005 2 1 61 67
21 Todea D, Cosma C, Dicu T, Rosca L, Dinu AC, Risteiu M, et al. Lung cancer risk induced by residential radon in CLUJ and Alba Counties, ROMANIA. Environmental Engineering and Management Journal . 2013;12(6): 1281–1285. 10.30638/eemj.2013.157 Todea D Cosma C Dicu T Rosca L Dinu AC Risteiu M et al Lung
Carmen Ardelean, Daniel Lighezan, Raluca Morar, Sorin Pescariu and Stefan Mihăicuță
underlying cause of HF or it was a consequence of HF; thus, some studies demonstrated that EF decreased through the progression of valvular insufficiency.
If SAS is a truly established independent cardiometabolic risk factor and if SAS should be included in integrated cardiometabolic risk reduction management are questions still waiting for definitive answers ( 28 ).
Patients with SAS and HFpEF have been shown to be at a higher risk for stroke. CKD and aortic and tricuspid insufficiency are higher in the group with reduced EF compared to those with SAS